Jodi M. Lestner

1.1k total citations
18 papers, 818 citations indexed

About

Jodi M. Lestner is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Jodi M. Lestner has authored 18 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in Jodi M. Lestner's work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (9 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Jodi M. Lestner is often cited by papers focused on Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (9 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Jodi M. Lestner collaborates with scholars based in United Kingdom, United States and Australia. Jodi M. Lestner's co-authors include William Hope, David W. Denning, Susan J. Howard, Eliane M. Billaud, Caroline B. Moore, Steven A. Roberts, Joanne Goodwin, Mike Sharland, Lea Gregson and Jayesh B. Majithiya and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Jodi M. Lestner

18 papers receiving 792 citations

Peers

Countries citing papers authored by Jodi M. Lestner

Since Specialization

Citations

This map shows the geographic impact of Jodi M. Lestner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi M. Lestner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi M. Lestner more than expected).

Fields of papers citing papers by Jodi M. Lestner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi M. Lestner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi M. Lestner. The network helps show where Jodi M. Lestner may publish in the future.

Co-authorship network of co-authors of Jodi M. Lestner

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi M. Lestner. A scholar is included among the top collaborators of Jodi M. Lestner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi M. Lestner. Jodi M. Lestner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study 2019 ·Antimicrobial Agents and Chemotherapy ·William Hope, (unknown), Silvia Cicconi, Timothy Felton, Joanne Goodwin, Sarah Whalley, (unknown), V. Ramos-Martín, Jodi M. Lestner, (unknown), Aaron Dane, Daniel F. Carr, Munir Pirmohamed, (unknown), Michael Neely	19
2	Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease 2018 ·Antimicrobial Agents and Chemotherapy ·Gemma L. Nixon, Laura McEntee, Adam Johnson, Nicola Farrington, Sarah Whalley, Joanne Livermore, (unknown), (unknown), Jaclyn Bibby, Neil G. Berry, Jodi M. Lestner, (unknown), Andrew Owen, David G. Lalloo, Ian G. Charles, William Hope	36
3	Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy 2017 ·Antimicrobial Agents and Chemotherapy ·Matthew Zimmerman, Jodi M. Lestner, Brendan Prideaux, Paul E. O’Brien, Isabela Dias-Freedman, Chao Chen, (unknown), Isaac Daudelin, Firat Kaya, Landry Blanc, Pei‐Yu Chen, Steven Park, Padmini Salgame, Jansy P. Sarathy, Véronique Dartois	58
4	Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis 2017 ·Antimicrobial Agents and Chemotherapy ·Jodi M. Lestner, Laura McEntee, Adam Johnson, Joanne Livermore, Sarah Whalley, Julie Schwartz, John R. Perfect, Thomas S. Harrison, William Hope	27
5	Vancomycin toxicity in neonates 2016 ·Current Opinion in Infectious Diseases ·Jodi M. Lestner, L. Hill, Paul T. Heath, Mike Sharland	46
6	Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children 2016 ·Antimicrobial Agents and Chemotherapy ·Jodi M. Lestner, Andreas H. Groll, Ghaith Aljayyoussi, Nita L. Seibel, Aziza Shad, Corina Gonzalez, Lauren V. Wood, Paul Jarosinski, Thomas J. Walsh, William Hope	30
7	Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology 2014 ·Advanced Drug Delivery Reviews ·Charlotte Barker, Eva Germovsek, (unknown), Jodi M. Lestner, Joanna Lewis, Joseph F. Standing	30
8	Systemic Antifungal Prescribing in Neonates and Children: Outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study 2014 ·Antimicrobial Agents and Chemotherapy ·Jodi M. Lestner, Ann Versporten, Katja Doerholt, Adilia Warris, Emmanuel Roilides, Mike Sharland, Julia Bielicki, Herman Goossens	39
9	Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections 2013 ·Expert Opinion on Drug Metabolism & Toxicology ·Jodi M. Lestner, William Hope	93
10	Unusual neuroradiological features in Schinzel–Giedion syndrome 2012 ·Clinical Dysmorphology ·Jodi M. Lestner, (unknown), (unknown), Jonathan Kefas, Anthony M. Vandersteen	11
11	Delineating the 17q24.2–q24.3 microdeletion syndrome phenotype 2012 ·European Journal of Medical Genetics ·Jodi M. Lestner, Richard J. Ellis, Natalie Canham	24
12	Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective 2012 ·British Journal of Clinical Pharmacology ·Jodi M. Lestner, P. Brian Smith, Michael Cohen‐Wolkowiez, Daniel K. Benjamin, William Hope	34
13	Renal impairment with sitagliptin: is there a need for active monitoring of potential renal toxicity? 2011 ·British Journal of Hospital Medicine ·Jodi M. Lestner, (unknown), C. M. B. Edwards	10
14	Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy 2011 ·The Journal of Infectious Diseases ·Susan J. Howard, Jodi M. Lestner, Joanne Sharp, Lea Gregson, Joanne Goodwin, Joanne Slater, Jayesh B. Majithiya, Peter Warn, William Hope	81
15	Tremor: a newly described adverse event with long-term itraconazole therapy 2010 ·Journal of Neurology Neurosurgery & Psychiatry ·Jodi M. Lestner, David W. Denning	17
16	Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis 2010 ·Antimicrobial Agents and Chemotherapy ·Jodi M. Lestner, Susan J. Howard, Joanne Goodwin, Lea Gregson, Jayesh B. Majithiya, Thomas J. Walsh, Gerard M. Jensen, William Hope	51
17	Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring 2009 ·Clinical Infectious Diseases ·Jodi M. Lestner, Steven A. Roberts, Caroline B. Moore, Susan J. Howard, David W. Denning, William Hope	102
18	Therapeutic drug monitoring for triazoles 2008 ·Current Opinion in Infectious Diseases ·William Hope, Eliane M. Billaud, Jodi M. Lestner, David W. Denning	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact